Stock Symbol:

EPCT

Company Name:

EpiCept Corporation

Company Description:

EpiCept Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of cancer and pain in the United States and Germany. Its lead product, Ceplene, is used for the treatment of acute myeloid leukemia.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

M-J-S-D

Stock Exchange:

NASDAQ

Predicted Split Price:

$19.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

3.2%

Prior Stock Splits:

1

Stock Split History:

Jan 15, 2010 [1:3]

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.